Pennant Investors »

Zentalis Pharmaceuticals shares owned by Pennant Investors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-06-30 $133k 32k 4.09
2024-03-31 $511k 32k 15.76

More positions owned by Pennant Investors

Echostar Corp Cl A (SATS)
Antero Res (AR)
Perimeter Solutions Sa Common Stock (PRM)
Micron Technology (MU)
Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Vertiv Holdings Com Cl A (VRT)
Ge Vernova (GEV)
Valmont Industries (VMI)
Core Scientific (CORZ)
Iris Energy Ordinary Shares (IREN)
Asml Holding N V N Y Registry Shs (ASML)
Grab Holdings *w Exp 99/99/999 (GRABW)

View all positions for Pennant Investors

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Eventide Asset Management
FMR
BlackRock
Vanguard Group
Decheng Capital
Citadel Advisors
Verition Fund Management
PRIMECAP Management Company
MPM Oncology Impact Management
Geode Capital Management
State Street Corporation
Two Sigma Advisers
D. E. Shaw & Co
Woodline Partners

View all funds holding Zentalis Pharmaceuticals